Logo 700 Pill - white oval, 19mm
Generic Name: doravirine
Pill with imprint Logo 700 is White, Oval and has been identified as Pifeltro 100 mg. It is supplied by Merck.
Pifeltro is used in the treatment of HIV Infection and belongs to the drug class NNRTIs. Pifeltro 100 mg is not a controlled substance under the Controlled Substances Act (CSA).
Images for Logo 700
Pifeltro
- Generic Name
- doravirine
- Imprint
- Logo 700
- Strength
- 100 mg
- Color
- White
- Size
- 19.00 mm
- Shape
- Oval
- Availability
- Prescription only
- Drug Class
- NNRTIs
- CSA Schedule
- Not a controlled drug
- Labeler / Supplier
- Merck
- National Drug Code (NDC)
- 00006-3069
- Inactive Ingredients
-
silicon dioxide,
croscarmellose sodium,
hypromellose acetate succinate,
microcrystalline cellulose,
magnesium stearate,
carnauba wax,
lactose monohydrate,
titanium dioxide,
triacetin
Note: Inactive ingredients may vary.
See also:
Biktarvy
Biktarvy is a complete HIV-1 treatment in a once-a-day single tablet containing three antiviral ...
Descovy
Descovy is used to treat and prevent HIV infection in adults and adolescents. When used for HIV-1 ...
Cabenuva
Cabenuva (cabotegravir and rilpivirine) injections are a long-acting HIV treatment used to keep HIV ...
Truvada
Truvada is used to prevent HIV (HIV PrEP) or treat HIV-1 infection in combination with other HIV-1 ...
Atripla
Atripla prevents the human immunodeficiency virus (HIV) from reproducing in your body. Learn about ...
Complera
Complera (emtricitabine, rilpivirine, and tenofovir) is used to treat HIV infection. Includes ...
Stribild
Stribild (cobicistat, elvitegravir, emtricitabine and tenofovir) is used to treat HIV-1 infection ...
Epzicom
Epzicom is used to treat HIV, which causes the acquired immunodeficiency syndrome (AIDS). Learn ...
Emtricitabine
Emtricitabine is used for HIV Infection, nonoccupational exposure, occupational exposure
More about Pifeltro (doravirine)
- Check interactions
- Compare alternatives
- Pricing & coupons
- Reviews (1)
- Drug images
- Side effects
- Dosage information
- During pregnancy
- FDA approval history
- Drug class: NNRTIs
- Breastfeeding
- En español
Patient resources
Professional resources
Related treatment guides
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.